$TCOM

Rosen Law Firm files securities class action against Trip.com Group ($TCOM), alleging false statements on business operations and regulatory risks. Investors urged to secure counsel before deadlines.

Trip.com faces securities fraud class action after China's antitrust regulator probes alleged monopolistic practices. Stock fell 19.4% in January 2026.

Schall Law Firm seeks investors in $TCOM securities purchased between April 2024-January 2026 for class action alleging fraudulent statements about monopolistic practices.

Kirby McInerney LLP filed class action lawsuit against $TCOM for allegedly understating monopoly investigation risks. Stock tumbled 17.1% after Chinese regulatory disclosure.

Trip.com investors alleging false regulatory disclosures can pursue class action. Stock dropped 19% after China antitrust investigation revelation.

Class action lawsuit filed against $TCOM for alleged securities fraud involving undisclosed monopolistic business risks. Lead plaintiff deadline set for May 11, 2026.

Rosen Law Firm launches securities class action against $TCOM for alleged material misstatements regarding regulatory risks and monopolistic practices. Lead plaintiff deadline: May 11, 2026.

Trip.com shares crashed 17% after Chinese regulators launched anti-monopoly probe into allegedly coercive AI pricing tool. Securities lawsuit filed.

Trip.com investors can file claims by May 11, 2026, in lawsuit alleging the company concealed Chinese antitrust investigation and monopolistic practice risks.

Trip.com faces securities fraud lawsuit over concealed antitrust investigation. Stock fell 17% when probe was disclosed.

Trip.com faces class action suit alleging antitrust disclosure failures. Stock plunged 19% after Chinese regulators' investigation revealed.

Trip.com ($TCOM) tumbled 17% after China's antitrust regulator launched investigation into alleged monopolistic practices. Lead plaintiff deadline set for May 11, 2026.

Trip.com shares crashed 17% amid Chinese antitrust probe into AI pricing tool allegedly forcing hotel discounts. Securities lawsuit filed; company shut tool down.

Law firm files class actions against uniQure, Gartner, and Trip.com for alleged failure to disclose material information. Stock declines range from 19% to 49%.

Trip.com faces securities fraud lawsuit after Chinese antitrust probe alleges monopolistic practices; stock fell 19.4%. Investors have until May 11, 2026 to file claims.

Gartner faces securities fraud suit after 48% stock decline linked to reduced guidance. Investors can apply as lead plaintiffs through Kahn Swick & Foti, LLC.

Driven Brands Holdings faces securities fraud class action over undisclosed financial statement errors spanning 2023-2025, triggering a 39% stock decline.

Class action lawsuit filed against Corcept Therapeutics alleging securities fraud tied to FDA rejection of relacorilant, triggering 50% stock plunge.

Law firm Bernstein Liebhard files securities fraud class action against $SLNO, citing alleged misrepresentations regarding Phase 3 DCCR clinical trial program.

Trip.com faces securities lawsuit after 19% stock plunge following China antitrust investigation disclosure. Lead plaintiff deadline set for May 11, 2026.